CSCID · COSCIENS Biopharma Inc.
$5.50
+0.10 (+1.85%)
At close · Jul 23
Market Cap
$5.48M
Shares
996,166
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.50
Open$5.50
Day$5.50–5.50
52W$2.37–12.60
Avg vol 30d1K
Short int2K · 0.2% float · 1.0d
Short vol99%
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−9%
below
Price vs 50-day avg
−9%
below
RSI (14)
40
neutral
MACD trend
Negative
52-week position
31%
mid-range
Momentum
relative strength
1-month return
−8%
trailing
6-month return
−11%
trailing
YTD return
−11%
this year
Relative strength
−17%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $6 — 200d above 50d
Institutional flow
Distributing
-88% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.20% of float · ▼ -89.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
2 holders — near 1-yr low, contrarian setup
Squeeze score
20
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
111%
annualized · 1-yr
Max drawdown
−81%
past year
ATR
8.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−9%
Bearish
Price vs 50-day avg
−9%
Bearish
RSI (14)
40
Neutral
MACD trend
Negative
Bearish
52-week position
31%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $6 › 200d $6 — 200d above 50d
Institutional flow
Distributing
-88% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.20% of float · ▼ -89.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
2 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $2
Now $6 · 31%
52-wk high $13
vs 200-day avg -9%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CSCID
this stock
COSCIENS Biopharma Inc.
|
$5.48M | -11.0% | — | — | 0.2% |
|
ONC
BeOne Medicines Ltd.
|
$471.01B | +7.6% | +22179.2% | 958.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.16B | +4.4% | +46.2% | 28.3 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.78B | -15.4% | +20.8% | 16.0 | 3.3% |
|
ARGX
Argenx SE
|
$57.44B | +9.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
2
- % held
- 0.4%
- Net QoQ
- -22.9K sh
- Top holder
- TD Waterhouse Canada Inc.
Held
Float
Short & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CSCID | -4.4% | -7.9% | -10.6% | -19.9% | -11.0% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -2.7% | -8.5% | -16.9% | -18.8% | -19.3% |